It’s time for a different solution

FUROSCIX, a subcutaneous formulation of furosemide, can help overcome challenges in treating fluid overload:

Bypasses the GI tract to provide 99.6% bioavailability—

even in the presence of fluid overload1

reaches therapeutic plasma furosemide levels within 30 minutes*

with urine output as early as 60 minutes1,2

Is self-administered at home through an on-body infusor1,3

Learn more about FUROSCIX efficacy

FUROSCIX delivers a fixed 80 mg of medication over 5 hours4:

  • 30 mg in the first hour
  • 12.5 mg per hour for the next 4 hours

*

Based on mean ± SD 30-minute plasma concentration of 600 (± 209) ng/mL.1
SD=standard deviation.

FUROSCIX can be used from the earliest signs of fluid overload to worsening symptoms5

Consider FUROSCIX for appropriate patients who are experiencing fluid overload symptoms despite maintenance diuretic treatment

Some common symptoms include7

RAPID WEIGHT GAIN

DYSPNEA

TROUBLE SLEEPING

or lying down

EDEMA

mostly in the lower extremities and abdomen

FUROSCIX is indicated for the treatment of edema (i.e., congestion, fluid overload, or hypervolemia) in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.

FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical.

Early intervention

Encourage your patients to recognize and report symptoms of fluid overload as soon as they present. This allows you the opportunity to offer them earlier at-home symptom relief.

FUROSCIX was designed for ease of use at home

  • Delivered directly to patients’ homes as a complete, ready-to-use kit with pre-programmed On-Body Infusor and pre-filled cartridge
  • Minimal preparation is needed by patients or caregivers, and the On-Body Infusor functionality is easily understood
  • Each On-Body Infusor is single use
  • While using FUROSCIX, patients can perform many normal, at-home activities

Learn more about FUROSCIX use